Login / Signup

Efficacy and Safety of Tinzaparin Thromboprophylaxis in Lung Cancer Patients with High Thromboembolic Risk: A Prospective, Observational, Single-Center Cohort Study.

Marousa KouvelaMaria Effrosyni LivanouDimitra T StefanouIoannis A VathiotisFotini SarropoulouMaria GrammoustianouEvangelos DimakakosNikolaos K Syrigos
Published in: Cancers (2024)
Thromboprophylaxis with an intermediate Tinzaparin dose in high thrombotic-risk lung cancer patients is a safe and effective choice for the prevention of VTE.
Keyphrases
  • venous thromboembolism
  • direct oral anticoagulants
  • atrial fibrillation
  • decision making